- -- 05 June 2010
- immatics announces Phase II Results with its Therapeutic Cancer Vaccine IMA901 in Patients with Advanced Renal Cell Carcinoma at ASCO
- -- 05 June 2010
- IMA901 data poster presented at ASCO Annual Meeting available for download now!
- -- 02 June 2010
- immatics enters Collaboration with the National Cancer Institute (NCI) to Advance the Development of IMA950 for Glioblastoma
- -- 17 May 2010
- IMA901 Phase II data presented at ASCO Annual Meeting in Chicago (June, 4-8)
- -- 17 May 2010
- Progress in preclinical projects presented at CIMT Annual Meeting (May, 26-28)
- -- 21 April 2010
- AACR Annual Meeting 2010 posters now available for download
- -- 16 February 2010
- immatics Enters Collaboration with Cancer Research UK to Develop Multi-target Rationally Designed Therapeutic Cancer Vaccine
IMA901 Phase II data presented at ASCO Annual Meeting in Chicago (June, 4-8)
Tuebingen, May 2010 –
Clinical Abstract will be presented on:
- Saturday, June 5th, 2010 - 2:00 PM - 6:00 PM
Genitourinary (nonprostate) cancer -
Results of a randomized phase 2 study investigating multi-peptide vaccination with IMA901 in advanced renal cell carcinoma
(Poster discussion session, E450a , Abstract ID 4529)
- Saturday, June 5th, 2010 - 5:00 PM - 6:00 PM
Genitourinary (nonprostate) cancer -
Results of a randomized phase 2 study investigating multi-peptide vaccination with IMA901 in advanced renal cell carcinoma
(Poster presentation, E Hall D2)
Immunological Abstract will be presented on:
- Monday, June 7th, 2010 - 8:00 AM - 12:00 PM
Developmental Therapeutics - Clinical Pharmacology and Immunotherapy -
Correlation of immune responses with survival in a randomized phase II study investigating multipeptide vaccination with IMA901 plus or minus low-dose cyclophosphamide in advanced renal cell carcinoma (RCC)
(General poster session, S Hall A2 , Abstract ID 2587)
We are looking forward to meeting you there!
http://chicago2010.asco.org/Home.aspx